cDNA cloning and mapping of a novel subtype of glutamine:fructose-6-phosphate amidotransferase (GFAT2) in human and mouse
about
Mutations in gfpt1 and skiv2l2 cause distinct stage-specific defects in larval melanocyte regeneration in zebrafishGenome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson diseaseChanges in the transcriptional profile of transporters in the intestine along the anterior-posterior and crypt-villus axesStructural analysis of human glutamine:fructose-6-phosphate amidotransferase, a key regulator in type 2 diabetesFunctional regulation of glutamine:fructose-6-phosphate aminotransferase 1 (GFAT1) of Drosophila melanogaster in a UDP-N-acetylglucosamine and cAMP-dependent mannerGlutathione depletion and acute exercise increase O-GlcNAc protein modification in rat skeletal muscle.Finding the missing link between the unfolded protein response and O-GlcNAcylation in the heart.O-GlcNAc signaling: a metabolic link between diabetes and cancer?Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect.Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia.Derivation of a novel undifferentiated human foetal phenotype in serum-free cultures with BMP-2.Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system.Exercise training increases protein O-GlcNAcylation in rat skeletal muscleDifferential hexosamine biosynthetic pathway gene expression with type 2 diabetes.Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer.O-GlcNAc and the cardiovascular system.High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma.Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.Protein O-GlcNAcylation in diabetes and diabetic complications.The effect of peri-conception hyperglycaemia and the involvement of the hexosamine biosynthesis pathway in mediating oocyte and embryo developmental competence.O-GlcNAc protein modification in C2C12 myoblasts exposed to oxidative stress indicates parallels with endogenous antioxidant defense.Computational prediction and experimental validation of evolutionarily conserved microRNA target genes in bilaterian animals.Phosphorylation of mouse glutamine-fructose-6-phosphate amidotransferase 2 (GFAT2) by cAMP-dependent protein kinase increases the enzyme activity.Kinetic characterization of human glutamine-fructose-6-phosphate amidotransferase I: potent feedback inhibition by glucosamine 6-phosphate.O-GlcNAcylation Reduces Ischemia-Reperfusion-Induced Brain Injury.Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathwayOverexpression of the complementary DNA for human glutamine:fructose-6-phosphate amidotransferase in mesangial cells enhances glucose-induced fibronectin synthesis and transcription factor cyclic adenosine monophosphate-responsive element binding phMutations in GFPT1-related congenital myasthenic syndromes are associated with synaptic morphological defects and underlie a tubular aggregate myopathy with synaptopathy.Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.GFPT1;2 transfer an amino group from L-Gln to F6P to form GlcN6PGlutamine: fructose-6-phosphate amidotransferase (GFAT): homology modelling and designing of new inhibitors using pharmacophore and docking based hierarchical virtual screening protocol.O-GlcNAc cycling in the developing, adult and geriatric brain.AMP-Activated Protein Kinase and O-GlcNAcylation, Two Partners Tightly Connected to Regulate Key Cellular ProcessesCongenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations
P2860
Q21145228-0DE9952B-9CB0-4B02-BE05-FA5DD6FF4AE0Q24596763-A31B0261-02DA-4494-828F-CAED0CC54DEFQ24810345-0585F4AE-C178-4BDB-81C1-7E553C0E5348Q27653066-2E15D517-F5CC-4DEB-A0D0-1D30BBA6D7D1Q28364618-4715C7BA-9C27-45BC-812B-A50496637596Q30368871-9AA63D77-3C1F-48B0-86BC-BDE26DDE2758Q34127646-55FF304A-5E34-407E-B60C-DDFDE8274E75Q34172895-9252354A-BAA7-4C2F-81A6-952C2C178EF0Q34560899-42F3F6D6-C096-400C-BBEE-50535464FAEFQ35183015-EA083393-E137-4E4B-AF1A-6646CFF00377Q36199189-B9C44635-A3DA-401B-B468-FF395DBBA7F7Q37088282-9B3D4653-127E-4C3D-A6C4-5956D25EDEA1Q37286799-58FC9F86-124F-4433-871F-AA9BA0090A8BQ37434092-67A6ACDE-82B1-46B7-A257-943ABB15ACC8Q37437526-9F1CED89-910B-407D-B873-166C4E755B01Q37619691-07A69F05-B5B1-4D36-92F2-E0073D5E16B6Q37745961-051C5DFE-2EAA-45FF-8CCD-DB18186B4B43Q37924015-2D8EC308-2C1F-4C3F-9230-7B10C9A52028Q38132916-02EB6E3A-7F81-4365-9804-2C8ADC5CEA72Q38177732-43B4EE0F-8FD7-41D7-872F-E04EFE9C55B7Q38934434-0F89A31A-C772-42F3-9570-001D490FB43DQ39437357-F42A4029-6692-4690-8C36-8A64C3841A86Q40558041-3DC013FA-8B3A-469A-91F8-C929273F7B25Q40751230-9BF1C4EB-B0D4-4184-9F47-5A7F7FA79239Q41636573-81C4650B-AEE6-41C1-9056-1AD4BF458536Q42339288-A4111CB5-ED48-4A64-80CB-48B7FDB1847BQ44311052-C86DD9D1-8238-40CB-A4D9-2ACA8F83CCBCQ48120299-341B4F11-06AA-4F23-A325-41E7539E2913Q50098159-E535DD72-36A5-498F-92CD-33F9F03F278FQ50296196-87FF3AA9-8ED2-47BE-83D6-19D9D06DCB0DQ50907551-9491F926-6CD9-4F5C-9801-2D7DA4278FDCQ55416370-3A0CEF6F-363D-420B-B742-921201B2C299Q57110459-DAFD824B-7BC5-46B6-A260-936363863B72Q57334284-996EF578-61EA-48B9-A941-0750FD4B2914
P2860
cDNA cloning and mapping of a novel subtype of glutamine:fructose-6-phosphate amidotransferase (GFAT2) in human and mouse
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
cDNA cloning and mapping of a ...... ase (GFAT2) in human and mouse
@ast
cDNA cloning and mapping of a ...... ase (GFAT2) in human and mouse
@en
cDNA cloning and mapping of a ...... ase (GFAT2) in human and mouse
@en-gb
cDNA cloning and mapping of a ...... ase (GFAT2) in human and mouse
@nl
type
label
cDNA cloning and mapping of a ...... ase (GFAT2) in human and mouse
@ast
cDNA cloning and mapping of a ...... ase (GFAT2) in human and mouse
@en
cDNA cloning and mapping of a ...... ase (GFAT2) in human and mouse
@en-gb
cDNA cloning and mapping of a ...... ase (GFAT2) in human and mouse
@nl
prefLabel
cDNA cloning and mapping of a ...... ase (GFAT2) in human and mouse
@ast
cDNA cloning and mapping of a ...... ase (GFAT2) in human and mouse
@en
cDNA cloning and mapping of a ...... ase (GFAT2) in human and mouse
@en-gb
cDNA cloning and mapping of a ...... ase (GFAT2) in human and mouse
@nl
P2093
P3181
P356
P1433
P1476
cDNA cloning and mapping of a ...... ase (GFAT2) in human and mouse
@en
P2093
P304
P3181
P356
10.1006/GENO.1999.5785
P407
P577
1999-04-15T00:00:00Z